申请人:Pasternak Alexander
公开号:US20130217680A1
公开(公告)日:2013-08-22
This invention relates to compounds having structural Formula (I); and pharmaceutically acceptable salts thereof which are inhibitors of the Renal Outer Medullary Potassium (ROMK) channel (Kir 1.1). The compounds of Formula I are useful as diuretics and natriuretics and therefore are useful for the therapy and prophylaxis of disorders resulting from excessive salt and water retention, including cardiovascular diseases such as hypertension and chronic and acute heart failure.
本发明涉及具有结构式(I)的化合物及其药学上可接受的盐,它们是肾外髓质钾(ROMK)通道(Kir 1.1)的抑制剂。公式I的化合物可用作利尿剂和钠利尿剂,因此可用于治疗和预防由过度盐和水潴留引起的疾病,包括高血压和慢性和急性心力衰竭等心血管疾病。